Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-039127
Filing Date
2014-06-23
Accepted
2014-06-23 17:54:28
Documents
1
Period of Report
2014-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v382138_4.html 4  
1 OWNERSHIP DOCUMENT v382138_4.xml 4 6618
  Complete submission text file 0001144204-14-039127.txt   7980
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 340 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 340 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 340 DURHAM NC 27713
Business Address
Gilliss Catherine (Reporting) CIK: 0001611008 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35867 | Film No.: 14936028